NASDAQ: SNSE - Sensei Biotherapeutics, Inc.

六个月盈利: -20.96%
部门: Healthcare

促销时间表 Sensei Biotherapeutics, Inc.


关于公司

Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors.

更多详情
It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.

IPO date 2021-02-04
ISIN US81728A1088
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.senseibio.com
Цена ао 1.04
每日价格变化: +3.92% (0.4792)
每周价格变化: +10.69% (0.4499)
每月价格变化: -10.35% (0.5555)
3个月内价格变化: -10.35% (0.5555)
六个月内的价格变化: -20.96% (0.6301)
每年价格变化: -28.03% (0.692)
3年内价格变化: -91.31% (5.73)
5年内价格变化: 0% (0.498)
10年价格变化: 0% (0.498)
年初以来价格变化: +5.96% (0.47)

低估

姓名 意义 年级
P/S 0 0
P/BV 0.2886 10
P/E 0 0
EV/EBITDA -0.3268 0
全部的: 3.75

效率

姓名 意义 年级
ROA, % -45.85 0
ROE, % -52.55 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.1701 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 169.24 10
盈利能力 EPS, % -20.78 0
全部的: 5.6



导师 职称 支付 出生年份
Mr. John K. Celebi M.B.A. President, CEO & Director 882.28k 1972 (53 年)
Dr. Edward Van der Horst Ph.D. Chief Scientific Officer 630.81k 1974 (51 年)
Ms. Lora Pike Vice President of Investor Relations & Communications N/A
Mr. Christopher W. Gerry J.D. Senior VP, General Counsel & Secretary N/A
Ms. Stephanie Krebs M.B.A., M.S. Chief Business Officer N/A 1978 (47 年)
Dr. Aaron Weitzman FACP, M.D., Ph.D. Chief Medical Officer N/A
Mr. Josiah Craver Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer

地址: United States, Rockville. MD, 1405 Research Boulevard - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.senseibio.com